# Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support

> **NCT03091998** · PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Heart Failure
- Left Ventricular Assist Device
- Natriuretic Peptide

## Interventions

- **DRUG:** CD-NP
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03091998
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-09-30
- **Primary completion:** 2019-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding available
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03091998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03091998, "Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03091998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*